Table 3.
Factors associated with intraocular pressure elevation after a fluocinolone acetonide intravitreal implant (mixed-model analysis)
| Fixed effects (reference) | Estimate | SE | P value | Lower 95% CI | Upper 95% CI |
|---|---|---|---|---|---|
| Age (years) | −0.05 | 0.02 | 0.041 | −0.91 | −0.01 |
| Sex (male) | 0.36 | 0.47 | 0.447 | −0.57 | 1.29 |
| IOP before injection (mmHg) | 0.58 | 0.07 | < 0.001 | 0.45 | 0.71 |
| Dexamethasone implant before FAc injection | −1.67 | 0.64 | < 0.001 | −2.92 | −0.41 |
| Previous IOP-lowering medication (none) | |||||
| Single therapy | 0.05 | 0.72 | 0.944 | −1.36 | 1.46 |
| Dual therapy | 1.04 | 0.77 | 0.176 | −0.47 | 2.56 |
| Triple therapy or more | 0.30 | 1.80 | 0.867 | −3.26 | 3.86 |
FAc fluocinolone acetonide, IOP intraocular pressure, SE standard error, 95% CI 95% confidence interval